Potential therapeutic strategies for lymphatic metastasis.
about
The role of EMT and MET in cancer disseminationThe Contribution of Angiogenesis to the Process of MetastasisLymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axisAbnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.Identification of genes regulating migration and invasion using a new model of metastatic prostate cancerVEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinomaListeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivChanges in specialized blood vessels in lymph nodes and their role in cancer metastasis.Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.Lymph nodes in gastric cancer.Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model.Drug resistance associated with antiangiogenesis therapy.Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic functionGene expression profile of lymphatic endothelial cells.The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1.Effects of aspirin on mesenteric lymph nodes of rabbits as basis for its use on lymph nodes metastases.All vessels are not created equal.Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer.
P2860
Q26796298-06290E00-774E-458D-86CD-3FD52192AB80Q26801841-44F47DE6-790D-44DF-89CB-7F21B36F6DF2Q26825144-35344533-A12A-4246-B22D-87574F1A7DD8Q30486123-7F69B09B-4DFF-48A9-8117-82E0462D8B6AQ33714753-F15CA5B3-62B2-4678-A1E0-958542EA34EEQ35087391-04488771-0563-4D9E-BC9E-25220D6A7629Q35543083-5B5D0524-DC4D-4390-BA91-C25CF41BE9F6Q35558123-AFC90958-A182-4233-B66F-1C78FC399CC2Q35695946-CCE5DA52-482E-4FC0-8D97-FCACB75E7A07Q36552441-6838B21B-C9EE-414D-9414-A0923A58D5BBQ36941258-914D1B93-69EA-46F7-80B1-2862D24B6251Q37249571-19B5EB4A-3159-4BA9-9DCB-31C522C763A8Q37282882-4D5C00A4-8F93-41B0-8051-E005C1FDA64BQ37518288-221638A2-14A3-4EE2-9B46-2101E6D2FBEFQ37781426-7EBD223D-DD2C-462B-A8B1-A9920EB58A6CQ37954393-4C6D9CF2-42BD-4350-BB8E-98B1666D4101Q38238738-DC368272-9472-4D29-9708-857CAAEAF91BQ39151249-7A7F08EA-11E1-43A3-A206-BFC33438A595Q39526888-4DECB379-5D4B-40A1-802B-7ED3C803CD0CQ47179466-9BD94273-8271-4571-891A-EF9A228556FEQ55044731-5BEB7BA4-041C-4B2B-A1AB-5FE5E93FC121
P2860
Potential therapeutic strategies for lymphatic metastasis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Potential therapeutic strategies for lymphatic metastasis.
@en
type
label
Potential therapeutic strategies for lymphatic metastasis.
@en
prefLabel
Potential therapeutic strategies for lymphatic metastasis.
@en
P2860
P1476
Potential therapeutic strategies for lymphatic metastasis.
@en
P2093
Bernadette M M Zwaans
Diane R Bielenberg
P2860
P304
P356
10.1016/J.MVR.2007.08.006
P577
2007-09-19T00:00:00Z